Mode
Text Size
Log in / Sign up
N/A Completed N=78 Randomized Double-blind Other

The Impact of Training With Whole Body-EMS

Healthy
Source: ClinicalTrials.gov NCT04288154 ↗
Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcomePrimary: Mean Change in Reactive Hyperemia Index (RHI) — 0.02; -0.26 score on a scale

Summary

Researchers are trying to find out what impact training with whole body-EMS (Electronic muscle stimulation) has on various health outcomes.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Change in Reactive Hyperemia Index (RHI)
0.02; -0.26
SECONDARY
Change in BMI
0.2; 0.06
SECONDARY
Change in Total Cholesterol
-1.7; 19.2
SECONDARY
Change in Maximal Oxygen Consumption (VO2max)
0.3; 1.1
SECONDARY
Mean Change in Quality-of-Life Score as Measured by the Longitudinal Amsterdam Aging Study (LASA) Questionnaire:
0.04; 0.3
SECONDARY
Change in Creatinine Kinase (CK)
417.9; -137.2
SECONDARY
Mean Change in Stress Score as Measured by the Perceived Stress Scale
-1.0; -0.4
SECONDARY
Mean Change in Depression Score as Measured by the Patient Health Questionnaire (PHQ-9)
-0.3; 0.05
SECONDARY
Change in Blood Glucose
0.7; -0.8
SECONDARY
Change in HbA1c
-0.01; 0
SECONDARY
Change in High Sensitivity C- Reactive Protein (CRP)
0.06; 0.3
SECONDARY
Change in Uric Acid:
0.1; 0.2
SECONDARY
Change in Fibrinogen
5.4; 9.0
SECONDARY
Change in Homocysteine
-6.7; -0.7
SECONDARY
Change in Lipoprotein
5.6; 15.4

Eligibility Criteria

Inclusion Criteria

  • Healthy individuals
  • Employees at the Mayo Clinic, Rochester, MN

Exclusion Criteria

  • Subjects under the age of 18
  • Pregnant women
  • Subjects with a history of liver or kidney disease, acute illness, taking medications (such as glucocorticoids)
  • Subjects who have conditions (such as chronic inflammatory muscular diseases or Cushing's syndrome) that affect muscle mass
  • Individuals with pacemakers and implantable cardiac defibrillators
  • Individuals who conduct any other type of resistance training (> 45 minutes/week)
  • Individuals who have regular "high" alcohol consumption (> 80g/day on 5 days a week)
  • Subjects unable to consent to or participate in the 16-week EMS intervention or be available for follow up
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04288154). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search